CLINICAL TRIALS PROFILE FOR QINLOCK
✉ Email this page to a colleague
All Clinical Trials for QINLOCK
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04530981 ↗ | A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients With Advanced GIST | Recruiting | Deciphera Pharmaceuticals LLC | Phase 1 | 2021-09-01 | Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Substrate |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for QINLOCK
Condition Name
Clinical Trial Locations for QINLOCK
Trials by Country
Clinical Trial Progress for QINLOCK
Clinical Trial Phase
Clinical Trial Sponsors for QINLOCK
Sponsor Name